An Update on the New York Noncompete Ban: It is Unlikely the Governor Will Sign It Anytime Soon

We wrote previously about how nobody seemed to be talking seriously about the noncompete bill that was passed by both the New York General Assembly and Senate last month. If signed by Governor Hochul, the bill would ban non-competes without a carveout even in the sale of a business context, which both California and the Federal Trade Commission’s proposed rule includes.

Luckily, in the weeks since we wrote that post it appears that people are finally taking notice. Several legal and industry organizations in New York have either submitted or are in the process of drafting letters or otherwise reaching …

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NovoCure Limited (“NovoCure” or “the Company”) (NASDAQ: NVCR) for violations of §§10(b) and 20(a) ) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the US Securities and Exchange Commission.

Investors who purchased the Company’s securities between January 5, 2023 and June 5, 2023, inclusive (the ”Class Period”), are encouraged to contact the firm before August 18, 2023.